|
Volumn 153, Issue 7, 2017, Pages 721-722
|
Pembrolizumab-induced extensive panniculitis and nevus regression: Two novel cutaneous manifestations of the post-immunotherapy granulomatous reactions spectrum
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE;
PEMBROLIZUMAB;
PREDNISONE;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PROGRAMMED DEATH 1 RECEPTOR;
ADULT;
ARTHRITIS;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG WITHDRAWAL;
FEMALE;
FEVER;
FOLLOW UP;
GRANULOMATOUS INFLAMMATION;
HUMAN;
LETTER;
MELANOMA;
MIDDLE AGED;
NEVUS;
PANNICULITIS;
PERIODIC ACID SCHIFF STAIN;
PERITONEUM METASTASIS;
PRIORITY JOURNAL;
REMISSION;
SKIN BIOPSY;
SKIN NODULE;
TREATMENT OUTCOME;
CHEMICALLY INDUCED;
DISEASE EXACERBATION;
IMMUNOTHERAPY;
PATHOLOGY;
PERITONEUM TUMOR;
SECONDARY;
SKIN;
SKIN TUMOR;
X-RAY COMPUTED TOMOGRAPHY;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOTHERAPY;
MIDDLE AGED;
NEVUS;
PANNICULITIS;
PERITONEAL NEOPLASMS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
SKIN;
SKIN NEOPLASMS;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 85024132571
PISSN: 21686068
EISSN: None
Source Type: Journal
DOI: 10.1001/jamadermatol.2017.0581 Document Type: Letter |
Times cited : (31)
|
References (6)
|